Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 25968 | 220 | 29.0 | 39% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 3476 | 1056 | EMBRYONAL CARCINOMA//TERATOCARCINOMA//HNT |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | JOINT EFFUSIONS | Author keyword | 1 | 33% | 1% | 2 |
| 2 | JUMPING HORSE | Author keyword | 1 | 50% | 0% | 1 |
| 3 | MED BLOOD TRANSFUS UNIT | Address | 1 | 50% | 0% | 1 |
| 4 | HISTOPHYSIOLNADA KU | Address | 0 | 33% | 0% | 1 |
| 5 | STANDARD BRED HORSE | Author keyword | 0 | 33% | 0% | 1 |
| 6 | UTAH ARTIFICIAL HEART | Address | 0 | 33% | 0% | 1 |
| 7 | ANTI PROLIFERATIVE DRUGS | Author keyword | 0 | 25% | 0% | 1 |
| 8 | APOLIPOPROTEIN B CONTAINING LIPOPROTEINS | Author keyword | 0 | 20% | 0% | 1 |
| 9 | CENT MED CHEM DIAG | Address | 0 | 17% | 0% | 1 |
| 10 | RGS1 | Author keyword | 0 | 14% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | JOINT EFFUSIONS | 1 | 33% | 1% | 2 | Search JOINT+EFFUSIONS | Search JOINT+EFFUSIONS |
| 2 | JUMPING HORSE | 1 | 50% | 0% | 1 | Search JUMPING+HORSE | Search JUMPING+HORSE |
| 3 | STANDARD BRED HORSE | 0 | 33% | 0% | 1 | Search STANDARD+BRED+HORSE | Search STANDARD+BRED+HORSE |
| 4 | ANTI PROLIFERATIVE DRUGS | 0 | 25% | 0% | 1 | Search ANTI+PROLIFERATIVE+DRUGS | Search ANTI+PROLIFERATIVE+DRUGS |
| 5 | APOLIPOPROTEIN B CONTAINING LIPOPROTEINS | 0 | 20% | 0% | 1 | Search APOLIPOPROTEIN+B+CONTAINING+LIPOPROTEINS | Search APOLIPOPROTEIN+B+CONTAINING+LIPOPROTEINS |
| 6 | RGS1 | 0 | 14% | 0% | 1 | Search RGS1 | Search RGS1 |
| 7 | IMMUNITY SYSTEM | 0 | 10% | 0% | 1 | Search IMMUNITY+SYSTEM | Search IMMUNITY+SYSTEM |
| 8 | DEPLETION FREE | 0 | 100% | 0% | 1 | Search DEPLETION+FREE | Search DEPLETION+FREE |
| 9 | ENOLASEL | 0 | 100% | 0% | 1 | Search ENOLASEL | Search ENOLASEL |
| 10 | GLYCOPHOSPHOLIPID ANCHORED GLYCOPROTEIN | 0 | 100% | 0% | 1 | Search GLYCOPHOSPHOLIPID+ANCHORED+GLYCOPROTEIN | Search GLYCOPHOSPHOLIPID+ANCHORED+GLYCOPROTEIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LDL IN | 1 | 33% | 1% | 3 |
| 2 | ISOLATED HUMAN LYMPHOCYTES | 1 | 22% | 1% | 2 |
| 3 | ANTI LAMININ IG | 0 | 25% | 0% | 1 |
| 4 | ADMISSION CRITERIA | 0 | 11% | 1% | 2 |
| 5 | BILAYER CHOLESTEROL | 0 | 20% | 0% | 1 |
| 6 | HYPERLIPEMIC SERUM | 0 | 14% | 0% | 1 |
| 7 | PSV2CAT DNA | 0 | 13% | 0% | 1 |
| 8 | IMMUNOREGULATORY LIPOPROTEIN | 0 | 11% | 0% | 1 |
| 9 | STATIONARY PRIMARY CULTURES | 0 | 11% | 0% | 1 |
| 10 | MYCOPLASMA MYCOIDES VAR | 0 | 100% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| LIPOPROTEIN INTERACTIONS WITH T-CELLS - AN UPDATE | 1990 | 29 | 51 | 29% |
| SYNOVIAL-FLUID LIPIDS AND APOLIPOPROTEINS - A CONTEMPORARY PERSPECTIVE | 1995 | 17 | 43 | 19% |
| THE IMMUNOLOGICAL ASPECTS OF ATHEROSCLEROSIS | 1989 | 0 | 10 | 50% |
| THE INFLUENCE OF HUMAN-PLASMA LIPOPROTEINS AND FATTY-ACIDS IN IMMUNOLOGICAL REACTIONS | 1984 | 6 | 19 | 47% |
| CURRENT DEVELOPMENTS IN PHYSIOLOGY AND PHARMACOLOGY | 1987 | 0 | 9 | 11% |
| IMMUNE-COMPLEXES AND ATHEROSCLEROSIS | 1982 | 0 | 13 | 31% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED BLOOD TRANSFUS UNIT | 1 | 50% | 0.5% | 1 |
| 2 | HISTOPHYSIOLNADA KU | 0 | 33% | 0.5% | 1 |
| 3 | UTAH ARTIFICIAL HEART | 0 | 33% | 0.5% | 1 |
| 4 | CENT MED CHEM DIAG | 0 | 17% | 0.5% | 1 |
| 5 | AGR SCINADA KU | 0 | 11% | 0.5% | 1 |
| 6 | CLIN EXPT SCI CES UNIT | 0 | 100% | 0.5% | 1 |
| 7 | GEN EXPTL PATHOL FRITZ PREGLSTR 3 | 0 | 100% | 0.5% | 1 |
| 8 | UNITE 15 35 | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000187931 | HYG PUBL HLTH MED//MESOGENESIS//TOKYO HLTH ADM |
| 2 | 0.0000108724 | SECT ENDOCRINOL DIABET METAB MC 797//CHOLESTEROL RICH DIETS//APOLIPOPROTEIN E ISOFORMS |
| 3 | 0.0000106876 | BOVINE LYMPHOCYTE//LYT2//S METHYLTHIO CYSTEINE |
| 4 | 0.0000106065 | SOUR CHERRY SEED EXTRACT//SOUR CHERRY KERNEL//ANTI PSYCHOTIC DRUG |
| 5 | 0.0000097930 | T CADHERIN//H CADHERIN//CDH13 |
| 6 | 0.0000087450 | SCAVENGER RECEPTOR//FRACTIONATED H 3HEPARIN//CLASS A SCAVENGER RECEPTOR |
| 7 | 0.0000085722 | OMEGA 3 LIPIDS//ENVIRONM RURAL HLTH//PROGRAM INTEGRAT NUTR COMPLEX DIS |
| 8 | 0.0000085546 | GLUCOSE AND GLUTAMINE//GLUCOSE AND GLUTAMINE METABOLISM//GLUTAMINE OXIDATION |
| 9 | 0.0000083135 | SR BI//SELECTIVE UPTAKE//HDL RECEPTOR |
| 10 | 0.0000075644 | TETRAHYDROCORTISOL//OUABAIN BINDING SITE//VEKTOR STATE VIROL BIOTECHNOL |